Ionis: Unveiling Exciting Insights! Get Ready for a Thrilling Showcase at the Upcoming September 2023 Investor Conferences

CARLSBAD, Calif., Aug. 30, 2023 /PRNewswire/ — Igniting Insights: Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) is Set to Ignite Investor Conversations at Prestigious September 2023 Conferences

Get ready for a power-packed series of insights as Ionis Pharmaceuticals takes center stage. Brace yourselves as Ionis unfolds its narrative at the upcoming investor conferences:

  1. 2023 Wells Fargo Healthcare Conference: Witness the sparks fly on Wednesday, September 6, 2023.
  2. Citi’s 18th Annual BioPharma Conference: Embark on an illuminating journey on Thursday, September 7, 2023.
  3. Morgan Stanley 21st Annual Global Healthcare Conference: Mark your calendars for a captivating encounter on Tuesday, September 12, 2023.

The stage is set, the anticipation is palpable—Ionis Pharmaceuticals is about to paint its vision on the canvas of these prestigious events.

About Ionis Pharmaceuticals

For over three decades, Ionis has been a trailblazer in the realm of RNA-targeted therapy, carving new paths and rewriting the rulebook for patient care. Throughout this journey, we’ve woven a tapestry of innovation that spans generations, ushering in change and setting new benchmarks.

Today, Ionis stands tall with four remarkable medicines already making their mark, and an exciting pipeline that’s poised to redefine cardiovascular and neurological landscapes.

But our story isn’t just about science; it’s about the lives we touch. For us, innovation is a responsibility, driven by the profound understanding that individuals battling illness are relying on us. This awareness fuels our grand vision—to be the pioneers of genetic medicine, leading the charge with a versatile arsenal that spans discovery, development, and life-altering deliveries.

The clock keeps ticking, and our passion continues to thrive, all because we know that our pursuit translates into better tomorrows for those who need it most.

Leave a Comment